Mesoblast Limited (NASDAQ:MESO) – Equities researchers at Oppenheimer Holdings issued their Q1 2019 earnings per share (EPS) estimates for Mesoblast Limited in a note issued to investors on Thursday. Oppenheimer Holdings analyst M. Breidenbach forecasts that the company will post earnings of ($0.23) per share for the quarter. Oppenheimer Holdings has a “Outperform” rating and a $16.00 price target on the stock. Oppenheimer Holdings also issued estimates for Mesoblast Limited’s Q2 2019 earnings at ($0.24) EPS, Q3 2019 earnings at ($0.26) EPS and Q4 2019 earnings at $0.02 EPS.

COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/10/01/mesoblast-limited-forecasted-to-post-q1-2019-earnings-of-0-23-per-share-meso.html.

MESO has been the topic of several other research reports. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Mesoblast Limited in a research note on Wednesday, August 23rd. Maxim Group set a $14.00 price objective on shares of Mesoblast Limited and gave the stock a “buy” rating in a research note on Wednesday, August 30th. BidaskClub cut shares of Mesoblast Limited from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th. Credit Suisse Group set a $11.00 target price on shares of Mesoblast Limited and gave the stock a “hold” rating in a report on Tuesday, July 18th. Finally, ValuEngine cut shares of Mesoblast Limited from a “hold” rating to a “sell” rating in a report on Friday, September 15th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $13.64.

Shares of Mesoblast Limited (NASDAQ:MESO) opened at 5.48 on Friday. Mesoblast Limited has a one year low of $4.01 and a one year high of $12.50. The firm has a 50 day moving average of $6.46 and a 200 day moving average of $8.22. The stock’s market cap is $465.49 million.

Mesoblast Limited Company Profile

Receive News & Stock Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related stocks with our FREE daily email newsletter.